Cancer Center Amsterdam

The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy

Korst, C. L. B. M., Tahri, S., Duetz, C., Bruins, W. S. C., de Jonge, A. V., de Jong, M. E., Fokkema, C., Smits, F., Groen, K., Verkleij, C. P. M., Frerichs, K. A., Papazian, N., van Duin, M., van Beek, G., Hoogenboezem, R., Baardemans, T., Dal Collo, G., Stoetman, E. C. G., Cosovic, M. & Twickler, I. & 15 others, Rentenaar, R., Eken, M., Homan-Weert, P. M., Saraci, E., D'Agostino, M., van der Velden, V. H. J., Sanders, M. A., Gay, F., Broijl, A., Moreau, P., Sonneveld, P., Zweegman, S., Mutis, T., Cupedo, T. & van de Donk, N. W. C. J., 19 Jun 2025, In: Blood. 145, 25, p. 3007-3014 8 p.

Research output: Contribution to journal › Article* › Academic › peer-review

Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphoma

de Jonge, A. V., Bruins, W. S. C., Duetz, C., Korst, C. L. B. M., Rentenaar, R., Cosovic, M., Eken, M., Kersten, M.-J., Sandberg, Y., van Rijn, R. S., Fijnheer, R., Mutsaers, P., Vergote, V. K. J., Issa, D., Beeker, A., Bilgin, Y. M., Visser, O., van Werkhoven, E., Roemer, M. G. M. & Chamuleau, M. E. D. & 1 others, Mutis, T., 1 Nov 2024, In: Haematologica. 109, 11, p. 3760-3761 2 p.

Research output: Contribution to journal › Article* › Academic › peer-review

Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma

Korst, C. L. B. M., O'Neill, C., Bruins, W. S. C., Cosovic, M., Twickler, I., Verkleij, C. P. M., le Clerre, D., Themeli, M., Chion-Sotinel, I., Zweegman, S., Galetto, R., Mutis, T. & van de Donk, N. W. C. J., 25 Jul 2024, In: Journal for Immunotherapy of Cancer. 12, 7, e008769.

Research output: Contribution to journal › Article* › Academic › peer-review